Biofrontera AG /
Keyword(s): Misc. matters /
Ad hoc: Biofrontera AG - FDA accepts filing of Ameluz® and BF-RhodoLED®
application
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content ...
↧